Phosphodiesterase Inhibitors
"Phosphodiesterase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.
Descriptor ID |
D010726
|
MeSH Number(s) |
D27.505.519.389.735
|
Concept/Terms |
Phosphodiesterase Inhibitors- Phosphodiesterase Inhibitors
- Phosphoric Diester Hydrolase Inhibitors
- Antiphosphodiesterases
- Phosphodiesterase Antagonists
|
Below are MeSH descriptors whose meaning is more general than "Phosphodiesterase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Phosphodiesterase Inhibitors".
This graph shows the total number of publications written about "Phosphodiesterase Inhibitors" by people in UAMS Profiles by year, and whether "Phosphodiesterase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 1 | 0 | 1 | 2019 | 0 | 1 | 1 | 2016 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2013 | 0 | 1 | 1 | 2010 | 0 | 1 | 1 | 2008 | 3 | 0 | 3 | 2007 | 0 | 1 | 1 | 2006 | 2 | 0 | 2 | 2005 | 0 | 1 | 1 | 2004 | 1 | 0 | 1 | 2003 | 0 | 3 | 3 | 2002 | 0 | 1 | 1 | 2000 | 1 | 0 | 1 | 1998 | 0 | 1 | 1 | 1992 | 1 | 0 | 1 | 1991 | 0 | 1 | 1 | 1988 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Phosphodiesterase Inhibitors" by people in Profiles over the past ten years.
-
Banerjee S, Norman DD, Deng S, Fakayode SO, Lee SC, Parrill AL, Li W, Miller DD, Tigyi GJ. Molecular modelling guided design, synthesis and QSAR analysis of new small molecule non-lipid autotaxin inhibitors. Bioorg Chem. 2020 10; 103:104188.
-
Matlock SM, Rush JL, Afzal W, Fulton EH, Berney SM, Wong HK. Spontaneous ulcerations of the breast. Clin Exp Dermatol. 2020 Jan; 45(1):107-110.
-
Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, Ashokkumar A, Bermel R, Ecklund D, Koepp M, Long J, Natarajan S, Ramachandran S, Skaramagas T, Thornell B, Yankey J, Agius M, Bashir K, Cohen B, Coyle P, Delgado S, Dewitt D, Flores A, Giesser B, Goldman M, Jubelt B, Lava N, Lynch S, Miravalle A, Moses H, Ontaneda D, Perumal J, Racke M, Repovic P, Riley C, Severson C, Shinnar S, Suski V, Weinstock-Gutman B, Yadav V, Zabeti A. Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis. Contemp Clin Trials. 2016 09; 50:166-77.
-
Goitia B, Rivero-Echeto MC, Weisstaub NV, Gingrich JA, Garcia-Rill E, Bisagno V, Urbano FJ. Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors. J Neurochem. 2016 Feb; 136(3):526-35.
-
Salous AK, Panchatcharam M, Sunkara M, Mueller P, Dong A, Wang Y, Graf GA, Smyth SS, Morris AJ. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J Lipid Res. 2013 Oct; 54(10):2775-84.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|